Published in J Transl Med on June 23, 2009
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res (2010) 2.11
Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett (2012) 1.37
Molecular targeting of glioblastoma: Drug discovery and therapies. Trends Mol Med (2011) 1.27
Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res (2012) 1.24
Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano (2014) 1.04
Polymeric Nanostructures for Imaging and Therapy. Chem Rev (2015) 0.99
Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano (2012) 0.96
Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med (2009) 0.95
Therapeutic nanomedicine for brain cancer. Ther Deliv (2013) 0.92
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
Intra-arterial chemotherapy for malignant gliomas: a critical analysis. Interv Neuroradiol (2011) 0.92
Challenges and opportunities in the advancement of nanomedicines. J Control Release (2012) 0.89
Which drug or drug delivery system can change clinical practice for brain tumor therapy? Neuro Oncol (2013) 0.88
Brain tumor-targeted drug delivery strategies. Acta Pharm Sin B (2014) 0.88
Nanoparticles squeezing across the blood-endothelial barrier via caveolae. Ther Deliv (2013) 0.83
Development of targeted therapies in treatment of glioblastoma. Cancer Biol Med (2015) 0.83
SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain. J Alzheimers Dis (2013) 0.82
Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clin Cancer Res (2016) 0.80
Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B (2016) 0.79
Bionanotechnology and the future of glioma. Surg Neurol Int (2015) 0.78
Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors. Ther Deliv (2010) 0.78
Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively. Cancer Res (2014) 0.78
COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICE. Drug Deliv Transl Res (2013) 0.77
Nanomaterial-Enabled Cancer Therapy. Mol Ther (2017) 0.77
Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle. J Nanomed Nanotechnol (2016) 0.76
Caveolae-mediated Delivery of Therapeutic Nanoparticles across Blood-endothelial Barrier. Austin J Anal Pharm Chem (2014) 0.76
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer. J Nanobiotechnology (2016) 0.75
Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma. Chem Sci (2017) 0.75
AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res (1996) 53.52
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol (2005) 5.60
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res (1986) 4.12
Microvascular permeability. Physiol Rev (1999) 4.12
Transport of molecules across tumor vasculature. Cancer Metastasis Rev (1987) 3.67
Studies on blood capillaries. I. General organization of blood capillaries in muscle. J Cell Biol (1968) 3.65
The endothelial surface layer. Pflugers Arch (2000) 3.40
Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci U S A (2003) 2.93
Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res (1997) 2.61
Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol (1999) 2.25
The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol (1996) 2.15
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res (2002) 2.09
Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol (2001) 1.73
Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target (2004) 1.65
Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer (2000) 1.60
Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J Physiol (1990) 1.60
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
Transport of macromolecules through microvascular walls. Cardiovasc Res (1996) 1.42
Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc Res Tech (2002) 1.40
Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc Res (1999) 1.38
Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol (1998) 1.31
The ultrastructure of frog mesenteric capillaries of known filtration coefficient. Q J Exp Physiol Cogn Med Sci (1979) 1.31
Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res (2002) 1.29
Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. J Neurol Sci (1972) 1.22
Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res (2000) 1.16
Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiol Scand (1985) 1.15
Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg (1983) 1.13
The acute intravenous toxicity of biological stains, dyes, and other fluorescent substances. Toxicol Appl Pharmacol (1978) 0.96
Quantitative STEM mass measurement of biological macromolecules in a 300 kV TEM. J Microsc (2007) 0.96
Determining molecular mass distributions and compositions of functionalized dendrimer nanoparticles. Nanomedicine (Lond) (2009) 0.95
Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition. Mol Pharm (2007) 0.86
Regional blood-to-tissue transport in RT-9 brain tumors. J Neurosurg (1983) 0.82
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
Protein oxidation implicated as the primary determinant of bacterial radioresistance. PLoS Biol (2007) 3.22
Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano (2009) 2.39
Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry (2002) 2.37
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Organization of the core structure of the postsynaptic density. Proc Natl Acad Sci U S A (2008) 2.06
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res (2010) 1.82
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol (2002) 1.69
Mass of the postsynaptic density and enumeration of three key molecules. Proc Natl Acad Sci U S A (2005) 1.67
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
PSD-95 is required to sustain the molecular organization of the postsynaptic density. J Neurosci (2011) 1.33
Nanoscale 3D cellular imaging by axial scanning transmission electron tomography. Nat Methods (2009) 1.32
Mitochondrial NADH fluorescence is enhanced by complex I binding. Biochemistry (2008) 1.30
Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett (2011) 1.24
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys. Clin Cancer Res (2005) 1.22
Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A (2006) 1.18
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy. Clin Cancer Res (2003) 1.12
Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel. Breast Cancer Res Treat (2004) 1.10
Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. Mol Biol Cell (2005) 1.09
Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab (2008) 1.06
A universal pretargeting system for cancer detection and therapy using bispecific antibody. Cancer Res (2003) 1.05
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine (Lond) (2010) 1.04
Improved iodine radiolabels for monoclonal antibody therapy. Cancer Res (2003) 1.03
Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest (2013) 1.03
Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras. J Virol (2004) 1.03
Self-assembly of amphiphilic plasmonic micelle-like nanoparticles in selective solvents. J Am Chem Soc (2013) 1.00
Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging. Chem Commun (Camb) (2010) 0.99
Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol (2010) 0.98
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET. Eur J Nucl Med Mol Imaging (2011) 0.97
Quantitative STEM mass measurement of biological macromolecules in a 300 kV TEM. J Microsc (2007) 0.96
Apolipoprotein E protects astrocytes from hypoxia and glutamate-induced apoptosis. FEBS Lett (2012) 0.95
Development of a MR-visible compound for tracing neuroanatomical connections in vivo. Neuron (2011) 0.95
Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor. J Neurosci (2009) 0.94
Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts. Cell Mol Neurobiol (2008) 0.93
Dual-axis electron tomography of biological specimens: Extending the limits of specimen thickness with bright-field STEM imaging. J Struct Biol (2010) 0.92
RGD-conjugated copolymer incorporated into composite of poly(lactide-co-glycotide) and poly(L-lactide)-grafted nanohydroxyapatite for bone tissue engineering. Biomacromolecules (2011) 0.91
Near-infrared fluorescence lifetime pH-sensitive probes. Biophys J (2011) 0.90
A new resorufin-based alpha-glucosidase assay for high-throughput screening. Anal Biochem (2009) 0.89
RESP18, a homolog of the luminal domain IA-2, is found in dense core vesicles in pancreatic islet cells and is induced by high glucose. J Endocrinol (2007) 0.89
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re. Clin Cancer Res (2003) 0.89
Development of humanized antibodies as cancer therapeutics. Methods (2005) 0.88
Effect of the charge state (z = -1, 0, +1) on the nuclear magnetic resonance of monodisperse Au25[S(CH2)2Ph]18(z) clusters. Anal Chem (2011) 0.88
Synthesis and characterization of a new fluorogenic substrate for alpha-galactosidase. Anal Bioanal Chem (2009) 0.88
Structure of the cytoskeleton of Spiroplasma melliferum BC3 and its interactions with the cell membrane. J Mol Biol (2008) 0.87
Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratios. Cancer Biother Radiopharm (2002) 0.87
Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM. J Struct Biol (2012) 0.86
Evaluation of bioreactor-cultivated bone by magnetic resonance microscopy and FTIR microspectroscopy. Bone (2006) 0.86
Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Clin Cancer Res (2005) 0.86
Localizing specific elements bound to macromolecules by EFTEM. Methods Cell Biol (2007) 0.86
Syntheses of meta-[F]Fluorobenzaldehyde and meta-[F]Fluorobenzylbromide from Phenyl(3-Formylphenyl) Iodonium Salt Precursors. J Labelled Comp Radiopharm (2011) 0.86
Cervical lymph node metastasis model of pyriform sinus carcinoma. ORL J Otorhinolaryngol Relat Spec (2009) 0.86
Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye. J Am Chem Soc (2009) 0.86
Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst (2009) 0.86
Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody. AIDS (2006) 0.85
Combining portable Raman probes with nanotubes for theranostic applications. Theranostics (2011) 0.85
Suturing silastic sheet from outside into larynx cavity: measurement of angles and clinical practice. Acta Otolaryngol (2013) 0.84
Development and application of STEM for the biological sciences. Ultramicroscopy (2012) 0.84
The efficacy of conversion from IUI to IVF-ET in infertility patients with hyper-response to ovulation induction: a retrospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2012) 0.84
Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life. J Transl Med (2009) 0.84
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates. Nucl Med Biol (2005) 0.84
Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance. ACS Nano (2014) 0.84
Expression and functional roles of Smad1 and BMPR-IB in glioma development. Cancer Invest (2009) 0.83
Imaging the distribution of individual platinum-based anticancer drug molecules attached to single-wall carbon nanotubes. Nanomedicine (Lond) (2009) 0.83
Effect of dimethyl sulfides on the induction of apoptosis in human leukemia Jurkat cells and HL-60 cells. Biosci Biotechnol Biochem (2008) 0.83
MRI-based prediction of pulsed high-intensity focused ultrasound effect on tissue transport in rabbit muscle. J Magn Reson Imaging (2013) 0.83
(89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies. Radiology (2015) 0.83
Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptor. Purinergic Signal (2008) 0.82
Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies. Technol Cancer Res Treat (2005) 0.82
Synthesis of ApoSense compound [18F]2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid ([18F]NST732) by nucleophilic ring opening of an aziridine precursor. Nucl Med Biol (2012) 0.82
Cryo-electron tomography of the magnetotactic vibrio Magnetovibrio blakemorei: insights into the biomineralization of prismatic magnetosomes. J Struct Biol (2012) 0.81
Direct visualization of CaMKII at postsynaptic densities by electron microscopy tomography. J Comp Neurol (2012) 0.81
Nuclear mapping of nanodrug delivery systems in dynamic cellular environments. ACS Nano (2012) 0.81
Synthesis, characterization, and direct intracellular imaging of ultrasmall and uniform glutathione-coated gold nanoparticles. Small (2012) 0.81
Polymorphisms of the IL8 gene correlate with milking traits, SCS and mRNA level in Chinese Holstein. Mol Biol Rep (2010) 0.81
A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Gene (2013) 0.81